{"id":1158936,"date":"2026-08-20T07:29:20","date_gmt":"2026-08-20T07:29:20","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/1158936\/"},"modified":"2026-08-20T07:29:20","modified_gmt":"2026-08-20T07:29:20","slug":"autoinjectable-pcsk9-inhibitor-caution-on-coq10-ohio-docs-rape-charges","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/1158936\/","title":{"rendered":"Autoinjectable PCSK9 Inhibitor; Caution on CoQ10; Ohio Doc’s Rape Charges"},"content":{"rendered":"

The FDA approved the autoinjector version of lerodalcibep (Lerochol)<\/a>, a PCSK9 inhibitor for LDL cholesterol lowering, LIB Therapeutics announced.<\/p>\n

Bracco Imaging announced FDA clearance of its VueJect contrast delivery system<\/a> for use with cardiac ultrasounds.<\/p>\n

The FDA alerted to Philips’ recall of over 2,600 Cardiac Workstation systems<\/a> due to a software issue related to inaccurate heart rate readings. Devices may continue to be used, albeit with manual corrections.<\/p>\n

Beware marketing claims promoting CoQ10 supplements<\/a>, cardiologists say. (Parade)<\/p>\n

Actress Hayden Panettiere<\/a> had been found in cardiac arrest before dying on Sunday at age 36. (ABC News)<\/p>\n

Bempedoic acid (Nexletol) reduced both cardiovascular and limb events to a notable degree among patients with peripheral artery disease<\/a>, according to the CLEAR Outcomes trial cohort. (Circulation)<\/p>\n

Self-proclaimed statin-intolerant people<\/a> were typically more wary of medication and healthcare professionals in general, a survey found. (European Journal of Preventive Cardiology)<\/p>\n

Serial cardiac MRI findings supported vutrisiran (Amvuttra)<\/a> for patients with transthyretin amyloid cardiomyopathy, based on the HELIOS-B trial. (JAMA Cardiology)<\/p>\n

An artificial intelligence-based ECG analyzer trained to flag structural heart disease<\/a> in a hospital-based cohort did less well in a community-based cohort. (Journal of the American College of Cardiology)<\/p>\n

A registry study did not support a link between pre-existing structural heart disease and post-COVID-19 complications<\/a>. (Heart)<\/p>\n

A draft Institute for Clinical and Economic Review report found the aldosterone synthase inhibitors baxdrostat (Baxfendy) and lorundrostat<\/a> only promising at best as a treatment for hypertension over spironolactone, eplerenone, or amiloride.<\/p>\n

In Sweden, people with atrial fibrillation and Alzheimer’s disease<\/a> showed modestly slower cognitive decline and a better efficacy-safety balance taking direct oral anticoagulants compared with warfarin or skipping anticoagulation altogether. (European Heart Journal)<\/p>\n

Electromechanical wave imaging via ultrasound<\/a> was introduced as a tool to map arrhythmogenic risks in mitral valve disease. (PNAS)<\/p>\n

Outpatient lung impedance-guided therapy<\/a> showed promise for heart failure with preserved ejection fraction, according to a small trial. (Journal of Cardiac Failure)<\/p>\n

Ohio’s state medical board suspended a cardiologist’s medical license<\/a> after he was arrested for alleged rape and sexual battery of patients. (Cincinnati Enquirer)<\/p>\n","protected":false},"excerpt":{"rendered":"The FDA approved the autoinjector version of lerodalcibep (Lerochol), a PCSK9 inhibitor for LDL cholesterol lowering, LIB Therapeutics…\n","protected":false},"author":2,"featured_media":1158937,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[4315],"tags":[54562,30114,38394,3386,1117,105,4326,16,15],"class_list":["post-1158936","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-alzheimer","tag-cardio","tag-cardiomyopathy","tag-covid","tag-covid-19","tag-health","tag-medication","tag-uk","tag-united-kingdom"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/117126664469242025","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/1158936","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=1158936"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/1158936\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/1158937"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=1158936"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=1158936"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=1158936"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}